Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Must See: 'ViewFinder: Food for Thought – Food Allergies'

European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...

US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut...

Update on Delivery of Emergency Epinephrine via Sublingual Film

FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents

Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...

FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray

Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...

DBV to Resubmit Application to FDA for Viaskin Peanut Approval in...

Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate

Follow Us

Your School On Our Map

Put Your School on the Map